Fisher & Paykel Healthcare’s share price is suffering today after lower-than-expected earnings guidance cast a question mark over its prospects post-pandemic.
In a release to the NZX this morning, the company said it expected to record operating revenue of between $1.675 billion and $1.7b for
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
